Akèy › Feokromositòm › Iowa
Etid klinik pou Feokromositòm nan Iowa
3 etid pou Feokromositòm ap chèche patisipan nan sit nan Iowa.
Vil nan Iowa
Tèks ofisyèl etid la (Anglè)
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- University of Iowa ( Site 0104), Iowa City
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04924075Project: Every Child for Younger Patients With Cancer
- Blank Children's Hospital, Des Moines
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- University of Iowa, Iowa City
Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.